Guardian Pharmacy Services, Inc. (NYSE:GRDN – Get Free Report) gapped up before the market opened on Thursday after an insider bought additional shares in the company. The stock had previously closed at $21.27, but opened at $22.04. Guardian Pharmacy Services shares last traded at $22.02, with a volume of 4,580 shares trading hands.
Specifically, Director Steven D. Cosler acquired 7,000 shares of the business’s stock in a transaction that occurred on Tuesday, November 19th. The shares were acquired at an average cost of $21.22 per share, with a total value of $148,540.00. Following the transaction, the director now owns 17,713 shares of the company’s stock, valued at $375,869.86. The trade was a 65.34 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Analysts Set New Price Targets
GRDN has been the topic of several recent research reports. Truist Financial lifted their price target on Guardian Pharmacy Services from $22.00 to $24.00 and gave the company a “buy” rating in a research note on Friday, November 15th. Stephens assumed coverage on Guardian Pharmacy Services in a research report on Tuesday, October 22nd. They set an “overweight” rating and a $21.00 price target for the company. Finally, Raymond James started coverage on shares of Guardian Pharmacy Services in a report on Monday, October 21st. They issued an “outperform” rating and a $21.00 price objective on the stock.
Guardian Pharmacy Services Price Performance
Guardian Pharmacy Services (NYSE:GRDN – Get Free Report) last posted its quarterly earnings results on Tuesday, November 12th. The company reported ($2.00) EPS for the quarter, missing analysts’ consensus estimates of $0.19 by ($2.19). The company had revenue of $314.39 million during the quarter, compared to analyst estimates of $303.21 million. As a group, analysts forecast that Guardian Pharmacy Services, Inc. will post 0.86 EPS for the current fiscal year.
Institutional Trading of Guardian Pharmacy Services
A number of hedge funds have recently modified their holdings of GRDN. Wellington Management Group LLP acquired a new position in shares of Guardian Pharmacy Services in the third quarter valued at approximately $8,400,000. Allspring Global Investments Holdings LLC bought a new stake in shares of Guardian Pharmacy Services in the third quarter valued at about $5,460,000. Maven Securities LTD acquired a new position in shares of Guardian Pharmacy Services in the third quarter valued at about $3,033,000. Seven Grand Managers LLC acquired a new stake in Guardian Pharmacy Services in the 3rd quarter worth about $2,515,000. Finally, Foundry Partners LLC acquired a new position in shares of Guardian Pharmacy Services during the 3rd quarter worth approximately $1,680,000.
About Guardian Pharmacy Services
Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.
See Also
- Five stocks we like better than Guardian Pharmacy Services
- 3 REITs to Buy and Hold for the Long Term
- Why Palo Alto Networks’ Multi-Year Uptrend is Far From Over
- Manufacturing Stocks Investing
- 3 Rock-Solid Buying Opportunities in the Market Right Now
- What does consumer price index measure?
- TJX Companies Stock Poised to Hit a New High This Year
Receive News & Ratings for Guardian Pharmacy Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardian Pharmacy Services and related companies with MarketBeat.com's FREE daily email newsletter.